肝硬化心肌病:病理生理学,评估,以及对肝移植的影响
Madeleine Gill1,2,3, Anoop N Koshy4,5, Jeyamani Ramachandran3,6
1Faculty of Medicine and Health, The University of Sydney, Science Road, Camperdown, Sydney, NSW 2050, Australia.
Therapeutic advances in gastroenterology
|February 26, 2026
概括
循环性心肌病变 (CCM) 是晚期肝病中的心脏功能障碍. 虽然不是肝移植的禁忌,但CCM增加了移植后的风险,需要仔细监测和管理.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 移植 移植 移植 移植
背景情况:
- 循环性心肌病变 (CCM) 是晚期慢性肝病中的心脏功能障碍.
- 它涉及透缩,有时是收缩功能障碍,与原发性心脏病无关.
- 门高血压和炎症的系统性影响加剧了CCM.
研究的目的:
- 审查目前关于CCM病理生理学,评估和肝移植 (LT) 的影响的知识.
- 突出诊断的进步和心脏储备的作用.
- 确定CCM管理的未来研究重点.
主要方法:
- 审查关于CCM的当前文献.
- 对诊断标准的分析,包括CCC-2020的定义.
- 讨论CCM对术前和术后LT结果的影响.
主要成果:
- CCM是一种压力不耐受的表型,对LT有影响.
- 亚临床CCM与LT后心力衰竭和不良心脏事件的增加有关.
- 在LT后的CCM恢复是可变的,可能不是普遍的.
结论:
- CCM需要积极的监测和定制的LT后管理,特别是心脏代谢多病症.
- 需要进一步研究风险预测模型和动态功能测试.
- 在CCM患者中探索心力衰竭疗法是首要任务.
相关概念视频
Cardiomyopathy V: Interprofessional Care
542
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
542
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
302
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
302
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Cardiomyopathy II: Dilated Cardiomyopathy
667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Kidney Transplant I: Introduction
586
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
586
Cardiomyopathy IV: Restrictive Cardiomyopathy
655
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
655


